EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uncovering the molecular mechanisms of amelanotic/hypopigmented primary cutaneous melanoma

Richard A Sturm iD, Darren J Smit iD, David L Duffy iD, Catriona McLean iD, Richard A Scolyer iD, Grant A McArthur iD, Anthony T Papenfuss iD, Mitchell S Stark iD, H Peter Soyer iD, Victoria J Mar iD

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Richard A Sturm und 9 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Skin Neoplasms, Melanoma, Amelanotic, Receptor, Melanocortin, Type 1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Centre of Research Excellence for the Study of Naevi, NHMRC Early Career Fellowship to M.S.S.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately 2–20% of cutaneous melanomas (CMs) are diagnosed as amelanotic/hypopigmented melanoma (AHM) and represent a challenge for early diagnosis.

Objectives

To investigate loss-of-function mutations in key pigmentation genes in matched germline and AHM, as well as pigmented melanoma (PM), tumour DNA samples.

Methods

Analysis of clinical and histopathological characteristics – together with whole-exome sequencing data of 34 fresh frozen primary CMs, graded according to the amount of pigmentation present – was performed. Together with germline and somatic variant analysis, 30 samples had previously been analysed for copy number aberration (CNA) changes. This study focused on germline and somatic variants in the coding region of 16 genes known to be associated with albinism/hypopigmentation or variation in human pigmentation in all samples. Chromosomal regions encompassing these 16 genes were examined for DNA copy loss or gain.

Results

The finding that red hair-related MC1R and TYR R402Q loss-of-activity gene variant alleles and genotypes are associated with AHM was confirmed. Germline AHM-related gene variants were enriched in 70% (n = 7/10) of patients with AHM vs. 8% (n = 2/24) of those with PM. This surprisingly high frequency of rare germline variants in people with AHM constitutes the ‘first hit’ and confirms that those with AHM are more likely to be albinism allele carriers than individuals with PM. Next, in CNA analysis of each tumour sample, 50% (n = 4/8) of AHM samples with a pigmentation gene variant had loss of heterozygosity (LOH) in the region containing the corresponding gene and 25% (n = 2/8) had LOH in chromosomal regions of two AHM-related genes.

Conclusions

This study proposes that the likely molecular mechanism for the development of amelanogenesis in AHM is carriage of an albinism/hypopigmentation allele followed by LOH of the corresponding gene in the tumour.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsMelanoma, AmelanoticReceptor, Melanocortin, Type 1HumansMaleFemaleMiddle AgedAgedGerm-Line MutationHypopigmentationExome SequencingMelanomaLoss of Function MutationDNA Copy Number VariationsAdultMonophenol MonooxygenaseAged, 80 and over

Substanzen

Receptor, Melanocortin, Type 1MC1R protein, humanMonophenol Monooxygenase

Autor:innen und Institutionen

  • Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia.
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Victorian Melanoma Service, The Alfred Hospital, Melbourne, VIC, Australia.
  • Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
  • Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

ORCID-Profile: Richard A Sturm, Darren J Smit, David L Duffy, Catriona McLean, Richard A Scolyer, Grant A McArthur, Anthony T Papenfuss, Mitchell S Stark, H Peter Soyer, Victoria J Mar

Förderung

  • National Health and Medical Research Council
  • Centre of Research Excellence for the Study of Naevi
  • NHMRC Early Career Fellowship to M.S.S
  • Australian Government
  • Victorian Cancer Agency
  • Melanoma Institute Australia

Zitieren

APA

Sturm, R. A., Smit, D. J., Duffy, D. L., McLean, C., Scolyer, R. A., McArthur, G. A., Papenfuss, A. T., Stark, M. S., Soyer, H. P., & Mar, V. J. (2024). Uncovering the molecular mechanisms of amelanotic/hypopigmented primary cutaneous melanoma. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae336

Vancouver

Sturm RA, Smit DJ, Duffy DL, McLean C, Scolyer RA, McArthur GA, et al. Uncovering the molecular mechanisms of amelanotic/hypopigmented primary cutaneous melanoma. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae336

BibTeX
@article{Sturm2024,
  author = {Sturm, Richard A and Smit, Darren J and Duffy, David L and McLean, Catriona and Scolyer, Richard A and McArthur, Grant A and Papenfuss, Anthony T and Stark, Mitchell S and Soyer, H Peter and Mar, Victoria J},
  title = {Uncovering the molecular mechanisms of amelanotic/hypopigmented primary cutaneous melanoma},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae336}
}
Kostenlos starten →